Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company in 2021 will be 185 million yuan to 205 million yuan, an increase of 173% to 203% year-on-year. The company’s bivalent HPV vaccine continued to maintain prosperous production and marketing, and its revenue and profit increased rapidly; As the covid-19 pneumonia epidemic has not been effectively controlled, the demand for overseas testing has increased significantly, and the company’s covid-19 raw material sales and overseas testing reagent export revenue have increased rapidly.
© China Stock Market News